chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Child developed small flat red rash on hands @ 5pm that progressed into redness, swelling and warmth of both hands by 7pm. Child did not have any other symptoms such as fever, systemic rash, aches, tingling, etc... Patient went to ER at 11pm and given Prednisone 1 tsp and Benadryl 1 tsp x 4 days. Swelling has now subsided by 11/11/09 and child has reddened, cracked hands, but no other sequelae.  Patient saw her pediatrician on 11/8/09.
At 0100, approximately 12hrs after receiving round two of the series, I started shivering uncontrollably. I would characterize this more as spasms than chills. I experienced steady dull muscle ache with occasional sharp jolts of pain, especially in my extremities. My joints began to ache severely and I was unable to sleep.  I registered a fever of 100.3 (my normal temperature is ~97.5). Additionally, I experienced nausea and a moderate headache. I shivered most of the evening and finally got out of bed at 0700. I immediately noticed that I was lethargic and fatigued. My doctor recommended I take 1000mg Tylenol to address the symptoms. This was effective, but only for two hours. After that my symptoms returned - most notably the fever and uncontrollable shivering. Symptoms appear to be declining at this point, approximately 31 hours after injection.
vaccine hurts too; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: vaccine hurts too). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  It was unknown if the company considered the pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 20-MAR-2023 This case was reported by a patient via interactive digital media. The reporter stated that the shingles vaccine hurt too. The follow up would not possible as no contact details were available.
Received the vaccine and developed a quarter sized rash on the elbow and it seemed to spread down the bony area down my arm. Wrist area on the bony part has a rash, up to the elbow, and up to the upper arm and shoulder, NOT in the muscle area... the bony areas. Both elbows, both arms. I showed up on the back of the neck for a few days, I applied cream, now it itches all  the way down the back and spine area. then the right knee, and then the left knee, the left knee rash went away but it is still on the right knee. It seems to be little itchy bumps on the raised bony areas of my body. it seems to want to spread to my stomach but its not as there is no bony areas there.  Blood pressure is high, have a constant headache. Low grade fever at night, Insomnia from itching. I have to go to the bathroom all night and I stop liquid intake after 8pm and I still have to urinate constantly at night.
Varicella rash post vaccine on 9/14/06 seen in office visit.
Arm mobility was restricted; My left arm was very painful at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Arm mobility was restricted) and VACCINATION SITE PAIN (My left arm was very painful at injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20Ai and 011L20A) for COVID-19 vaccination.     The patient's past medical history included Herpes simplex from 01-Jan-2021 to 02-Mar-2021. Concurrent medical conditions included Penicillin allergy, Hypothyroidism since 1983 and Essential hypertension since 2018. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) from 1989 to an unknown date, LIOTHYRONINE SODIUM (CYTOMEL) from 1995 to an unknown date and OLMESARTAN from 2018 to an unknown date for an unknown indication.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced MOBILITY DECREASED (Arm mobility was restricted) and VACCINATION SITE PAIN (My left arm was very painful at injection site). On 31-Jan-2021, MOBILITY DECREASED (Arm mobility was restricted) and VACCINATION SITE PAIN (My left arm was very painful at injection site) had resolved.            No treatment information was provided.   This case was linked to MOD-2021-002194 (Patient Link).
Fever, chills, muscle ache, muscle spasms and extreme fatigue. Lasted about 2 hours. Took Tylenol PM to relieve symptoms, seemed to have worked
First dose received on 12/30/2020 - no adverse effects. Second dose received 1/26/2021 - 15 hours after vaccine administration symptoms started - chills, nausea, fatigue, muscle cramps, headaches, fevers to 101.  All symptoms resolved within 24 hours.  While I know these symptoms can be expected, since this is a new vaccine with ongoing data collection, I am reporting my symptoms due to the vaccination.
Dizziness, delusional, irritable, sleepiness, loss of appetite, was told to wait at least two weeks to see if more reactions occur.
Dizziness, weakness, fatigue, would feel better for a few hours, then stayed in bed the entire next day, still on and off and it is 9-16-15.
Headaches daily.  Upper/top and foward on head. Short term memory getting worse.
Swelling to L arm from shoulder to above L elbow with pain, redness, swelling, warmth, induration and tight shiny appearance noted the morning after 2013 quadrivalent flu vax was given. Patient's first IM flu vax. Previous years received Flu Mist. Pictures available on request. Redness, pain, warmth and swelling increased the next day. PT was evaluated by MD, given oral prednisone to try for 24hr then to follow with Keflex if redness spread. Redness has increased and extended beyond margins from 11:30 am appt to 3:30pm.
Left arm feels like a brick is laying on it, occasionally I feel like something is wrapped tightly around my arm. Fatigue, dizziness/nausea, slight headache, chills, stuffy
Moderna COVID-19 Vaccine EUA Had Covid beginning 12/24/2020 with a positive test 12/28/2020.  Within 8 hours of receiving the first vaccine I got a bad headache, my chest felt heavy again, I was nauseated and felt a general malaise - all symptoms I had experienced with Covid.  These symptoms lightened over the next few days, but I developed a cough again, and my headache continued off and on through day 5.
Atrial Fibrillation episodes became much more frequent and longer lasting over the course of the next 24 days.
I received the Pfizer Booster shot on 11/12. I had no prior symptom's with prior shots. I had knee replacement surgery one month earlier (10/11/21) . I got the booster shot on 11/12. On 11/19, I broke our with rash/hives underarms, stomach. back, buttocks. Also had 2-3 short duration anaphylactic/ throat tightening events on 11/19. I was given Prednisone, 10Mg to clear the rash.
W/in 2 hrs p/immun, pt exp an inject site rxn which included swelling from the site of inject to elbow, tenderness & hot to touch; tx APAP & ice packs;
A nurse from a doctor's office reported that patient with no past medical history experienced fever of 103 degrees Fahrenheit, coughing and body aches 3 days after receiving FluMist vaccine on 04 Nov 2005.  The patient was seen at doctor's office and was given Tylenol and albuterol. On 08 Nov 05, the patient's mother called the doctor's office to report that the patient was still coughing, had body aches and low grade fever of 100 degrees Fahrenheit. The reporter causality is not provided. Additional information has been requested.
Pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Pain). At the time of the report, PAIN (Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medication were reported.
Pt crying & low grade fever began evening 5DEC91; pt continued to be fussy & had low grade fever thru 12DEC91 then taken to ER; had a screaming episode 12DEC; MD did sp tap; mom told pt had URI; rx: Ceclor; still ill -> ER admit to hosp;
Information has been received from a receptionist at the physician's office concerning a patient who in approximately April 2008 was vaccinated with ZOSTAVAX vaccine (Oka/Merck) (dose and administrating site not reported). The patient experienced a "break out" (unspecified as to what this exactly means) a few days after the shot. Subsequently, the patient recovered from break out (unspecified as to what this exactly means). Additional information has been requested.
Patient has experienced muscle pain, some swelling, and painful injection site since date of vaccination (>40 days) at reporting
a little nausea; low fever; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (a little nausea) and PYREXIA (low fever) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: PFIZER on 26-Apr-2021 and PFIZER on 17-May-2021. Past adverse reactions to the above products included No adverse event with PFIZER and PFIZER.    On 31-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (a little nausea) and PYREXIA (low fever). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Fever, at an unspecified dose and frequency. At the time of the report, NAUSEA (a little nausea) and PYREXIA (low fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: low fever (abnormal) low fever.         No concomitant medication was provided by the reporter.   This case was linked to MOD-2022-437606 (Patient Link).
No adverse event; Vaccine administered BUD; Dose 1-9-Jul-2022,Dose 2-10-Nov-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered BUD), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1-9-Jul-2022,Dose 2-10-Nov-2022) and NO ADVERSE EVENT (No adverse event) in a 3-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. AS1414B and AR9236B) for COVID-19 prophylaxis.     No Medical History information was reported.   On 09-Jul-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered BUD) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1-9-Jul-2022,Dose 2-10-Nov-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered BUD), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1-9-Jul-2022,Dose 2-10-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Vaccine administered BUD) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1-9-Jul-2022,Dose 2-10-Nov-2022).    Concomitant medication was not provided. Immunization Information System reported for the patient. For dose 1, Vaccine was received at vaccination center on 07-Jun-2022 and before use date was reported as 07-Jul-2022. For dose 2, Vaccine was received at vaccination center on 13-Sep-2022 and before use date was reported as 13-Oct-2022. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Dec-2022: Live Follow-up  Significant information accepted.
This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 71-year-old female patient who received Hepatitis A vaccine. Co-suspect products included Hepatitis A vaccine and Atorvastatin unknown for an unknown indication. Concomitant products included estradiol and PNEUMOVAX. On 28th August 2015, the patient received the 2nd dose of Hepatitis A vaccine. On 19th February 2015, the patient received the 1st dose of Hepatitis A vaccine. In September 2015, the patient started Atorvastatin at an unknown dose and frequency. On 30th September 2015, 33 days after receiving Hepatitis A vaccine, 223 days after receiving Hepatitis A vaccine and not applicable after starting Atorvastatin, the patient experienced vaccination failure (serious criteria GSK medically significant), hepatitis A, upper respiratory tract infection, chills, sweating, weakness, energy decreased and appetite absent. On 3rd October 2015, the patient experienced nausea, taste altered, tremor and fever. On 4th October 2015, the patient experienced urine discoloration. On an unknown date, the patient experienced elevated liver enzymes. On 3rd October 2015, the outcome of the upper respiratory tract infection, chills, sweating and appetite absent were recovered/resolved. On 4th October 2015, the outcome of the tremor and fever were recovered/resolved. On an unknown date, the outcome of the vaccination failure, hepatitis A and elevated liver enzymes were unknown and the outcome of the weakness, energy decreased, nausea and taste altered were recovering/resolving and the outcome of the urine discoloration was unchanged. It was unknown if the reporter considered the vaccination failure, hepatitis A, upper respiratory tract infection, chills, sweating, weakness, energy decreased, appetite absent, nausea, taste altered, tremor, fever, elevated liver enzymes and urine discoloration to be related to Hepatitis A vaccine, Hepatitis A vaccine and Atorvastatin. Additional details were provided as follows: The patient reported that she received her first dose of hepatitis A vaccine on 19th February 2015. She received her second dose on 28th August 2015. As of July 2015, her lab values were normal. The patient reported that around 30th September 2015 she started experiencing issues that included an upper respiratory infection, chills, sweating, low energy, no appetite and weakness. Over the past weekend beginning, 3rd October 2015 she experienced nausea, food tasted bad, shaking and a fever of 104 degrees Fahrenheit. The patient went to the doctor and after lab work was completed her results showed elevated liver enzymes including ALT, AST and Bilirubin. She reported that her Hepatitis A panel was reactive as well and she was told that she had Hepatitis A. This case was considered as a vaccination failure case. The patient stated that she started Atorvastatin about a month ago and she felt that this product was actually the cause of all of her issues and not the hepatitis A vaccine.
On 01/19/01, this patient received her vaccinations in the PM. Her arm started to swell, sting, and she complained of pain, and severe redness for several days. The patient took Tylenol when necessary and Ibuprofen for 2 days. Today the swelling and redness is decreased.
GI upset; diarrhea; This is a spontaneous report received from a non-contactable reporter(s) (Nurse).  A 28-year-old male patient received BNT162b2 (BNT162B2), on 14Dec2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 27 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot number: E6955), administration date: 29Mar2021, when the patient was 27-year-old, for Covid-19 immunization; BNT162b2 (DOSE 2, SINGLE; Lot number: EP6955), administration date: 19Apr2021, when the patient was 27-year-old, for COVID-19 immunization. The following information was reported: ABDOMINAL DISCOMFORT (non-serious) with onset 09Jun2022, outcome "unknown", described as "GI upset"; DIARRHOEA (non-serious) with onset 09Jun2022, outcome "unknown", described as "diarrhea". It was unknown if therapeutic measures were taken as a result of abdominal discomfort, diarrhoea.  Additional information: Prior to vaccination, the patient had not been affected with COVID-19. The patient had been tested for COVID-19 after the vaccination.  No follow-up attempts are possible. No further information is expected.
Repeated projectile vomiting on administration of vaccine, attempted three times in office with same recurrence of symptoms.
Headache on whole head, turned white as a sheet of paper, high fever, chills, nausea I think from headache and fever. Tingling and other feeling in both hands, like they were asleep feeling, dizzy, sweating and chills, still feel weak and headache but not as bad today.
Fever of 101.2, fatigue, injection site pain, bone pain in shoulder and clavicle, diarrhea, sore neck, sore throat, runny nose, sneezing, headache, dry cough.
Started getting shortness of breath several weeks after first injection.   I work out five days a week (recumbent & spin bikes and light weights) and about ten minutes into the workout that I?ve been doing for a year, I was short of breath.  Initially l, I was only short of breath when I exerted myself.  Then I started getting short of breath doing nothing.
I got mine the 20th and got diagnosed with a different flu on the 22nd; Initial information received on 06-Jan-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp via global digital media.  This case involves Adult of an unknown gender patient who reported i got mine the 20th and got diagnosed with a different flu on the 22nd ,while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (dose, formulation, lot number not reported via unknown route in unknown administration site) as prophylactic vaccination.  On an unknown date, the patient developed a non-serious event " i got mine the 20th and got diagnosed with a different flu on the 22nd" (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (I got mine the 20th and got diagnosed with a different flu on the 22nd).  At time of reporting, the outcome was Unknown for the event i got mine the 20th and got diagnosed with a different flu on the 22nd.
1/10Fatigue, 1/11 facial tingling to left side and eye brow area feeling heavy, 1/12 headache, 1/15 sore throat  1/16  left rib pain, wheezing, short of breath, fatigue 1/17 fatigue, chills, short of breath, wheeze, and loss of taste and smell. 1/18 I have a Telehealth visit with my Dr. Office at 12:40
Expired Vaccine administered. Pt did not have any negative effects. Stayed in store shopping for 2 hours and had no symptoms or signs of harm
On Friday, October 21 (8 days after the Covid vaccine), I went to the emergency room at Hospital with stomach discomfort.  It was determined that I had a twisted colon. There were no symptoms prior to this. Surgery was performed - about 1 1/2 of colon was removed and resectioned.  After surgery my hemoglobin levels dropped - no cause was determined. I was on iron for 2 weeks and pantoprazole for 8 weeks.
Began to develop limp swelling and erythema of left upper arm around 24 hours after receiving DTaP #5 , IPV #4 in left upper arm. No fever. Positive for pruritus. No pain. Clinical exam consistent with description of limp swelling with 4th and 5th DTaPs
This case was reported by a nurse via call center representative and described the occurrence of malaise in a 63-year-old female patient who received BOOSTRIX (batch number 3K799, expiry date 18th May 2019). On 11th July 2017, the patient received BOOSTRIX. On 18th July 2017, 7 days after receiving BOOSTRIX, the patient experienced malaise, fever, appetite lost, light headedness, skin sensitization, stomach pain, fatigue and nausea. On an unknown date, the outcome of the malaise, fever, appetite lost, light headedness, skin sensitization, stomach pain, fatigue and nausea were unknown. It was unknown if the reporter considered the malaise, fever, appetite lost, lightheadedness, skin sensitization, stomach pain, fatigue and nausea to be related to BOOSTRIX. Additional information was provided as follows: The age at vaccination was not reported, but it could be 62 or 63 years. One week after vaccination the patient experienced fever and skin that was sensitive all over the body. On 18th July 2017, the body temperature was recorded as 99.5 degree C. On 31st July 2017, the patient was seen by the doctor. The patient required emergency room visit. At the time of visit, the events were unchanged.
Patient received first dose of Moderna series at our institution.  He then transferred to another correctional facility for a court date out of state where he received the first dose of Janssen.
The side I had injections on is swollen and sore/the other side I had a lump/yesterday I noticed there's actually three pea sized lumps not just one; My armpit were sore/The side I had injections on is swollen and sore; This spontaneous case was reported by a patient and describes the occurrence of SWELLING (The side I had injections on is swollen and sore/the other side I had a lump/yesterday I noticed there's actually three pea sized lumps not just one) and MYALGIA (My armpit were sore/The side I had injections on is swollen and sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (The side I had injections on is swollen and sore/the other side I had a lump/yesterday I noticed there's actually three pea sized lumps not just one) and MYALGIA (My armpit were sore/The side I had injections on is swollen and sore). At the time of the report, SWELLING (The side I had injections on is swollen and sore/the other side I had a lump/yesterday I noticed there's actually three pea sized lumps not just one) and MYALGIA (My armpit were sore/The side I had injections on is swollen and sore) outcome was unknown.            Concomitant medication information was not reported by the reporter. Treatment information was not provided. The action taken with mRNA-1273 with the events was considered as not applicable.   Reporter did not allow further contact
Shot given Monday at approx 2:30pm itching right after adm., then later that evening had a large knot on arm that we treated with ice packs and BENADRYL. Then 2 days later (Wed.) day patient was unable to move her arm and by the end of day her fingers were swollen. Swelling went all the way thru breast. Getting better in 5 days.